PMC Biogenix Expands Manufacturing At Memphis, Tennessee, Plant
02/28/2017
According to company officials, the Memphis expansion project will increase its capacity for erucic and behenic acids by approximately 50% as well as double its output for C-20 fatty acids, and upgrades PMC’s production capabilities to the most current technologies. This expansion supports PMC’s expansion in fatty amides capacity at its Gyeongju, South Korea facility in 2016.
Erucic acid is the primary feedstock for PMC’s fatty amide slip agent product line which serves the growing polyolefins market. PMC produces a complete range of primary and secondary fatty amide slip agents in Memphis, TN and Gyeongju, South Korea for a wide range of polymers and coatings.
“The global polyolefins market relies on Kemamide and Armoslip slip agents for most slip and anti-torque applications,” said Dr. William Hayes, Vice President.
“Our investment in this new capacity underscores PMC’s strong global position in this segment and our commitment to supporting the growth of the global polyolefins market through expansion and continuous investment to ensure we are employing the state-of-the-art technologies,” Hayes added.
Project Announcements
Momentous Expands Summit County, Utah, Operations
12/21/2025
Stryker Expands Salt Lake County, Utah, Operations
12/21/2025
Portal Space Systems Expands Bothell, Washington, Operations
12/21/2025
TerraForge Biocarbon Solutions Plans Magnolia, Mississippi, Operations
12/20/2025
Coastal Ready Mix Plans Conway, South Carolina, Production Operations
12/20/2025
PRET Advanced Materials Expands Johnsonville, South Carolina, Manufacturing Operations
12/19/2025
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Rethinking Local Governments Through Consolidation and Choice
Q3 2025
-
Lead with Facts, Land the Deal
Q3 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
America’s Aerospace Reboot
Q3 2025
-
The Permit Puzzle and the Path to Groundbreaking
Q3 2025